Evidence map›Paper›PMID 42605805›Full record

ArticleNucleic acids research2026

Nuclear receptor Nur77 resolves the inflammatory response of macrophages primarily by regulating expression of AP-1 transcription factors and their target genes.

Sanne C Lith, Sebastian Gregoricchio, Claudia M van Tiel, Ingeborg van der Made, Beatriz M Freire, Simon Linder, Sanne Jacobs, Onno Bleijerveld, Liesbeth Hoekman, Guglielmo L Alonzo and 3 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sanne C LithAmsterdam UMC location, location Academic Medical Center, Department of Medical Biochemistry, University of Amsterdam, 1105AZ Amsterdam, The Netherlands.
Sebastian GregoricchioDivision of Oncogenomics, Netherlands Cancer Institute and Oncode Institute, 1066CX Amsterdam, The Netherlands.ORCID 0000-0001-9209-5403
Claudia M van TielAmsterdam UMC location, location Academic Medical Center, Department of Medical Biochemistry, University of Amsterdam, 1105AZ Amsterdam, The Netherlands.ORCID 0000-0001-7009-8320
Ingeborg van der MadeAmsterdam UMC location, location Academic Medical Center, Department of Medical Biochemistry, University of Amsterdam, 1105AZ Amsterdam, The Netherlands.ORCID 0000-0001-6251-8161
Beatriz M FreireAmsterdam UMC location, location Academic Medical Center, Department of Medical Biochemistry, University of Amsterdam, 1105AZ Amsterdam, The Netherlands.
Simon LinderDivision of Oncogenomics, Netherlands Cancer Institute and Oncode Institute, 1066CX Amsterdam, The Netherlands.ORCID 0000-0002-3315-305X
Sanne JacobsAmsterdam UMC location, location Academic Medical Center, Department of Medical Biochemistry, University of Amsterdam, 1105AZ Amsterdam, The Netherlands.
Onno BleijerveldMass Spectrometry/Proteomics Facility, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.
Liesbeth HoekmanMass Spectrometry/Proteomics Facility, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.
Guglielmo L AlonzoAmsterdam UMC location, location Academic Medical Center, Department of Medical Biochemistry, University of Amsterdam, 1105AZ Amsterdam, The Netherlands.
Wilbert ZwartDivision of Oncogenomics, Netherlands Cancer Institute and Oncode Institute, 1066CX Amsterdam, The Netherlands.ORCID 0000-0002-9823-7289
Marten A HoeksemaAmsterdam UMC location, location Academic Medical Center, Department of Medical Biochemistry, University of Amsterdam, 1105AZ Amsterdam, The Netherlands.ORCID 0000-0001-5981-121X
Carlie J M de VriesAmsterdam UMC location, location Academic Medical Center, Department of Medical Biochemistry, University of Amsterdam, 1105AZ Amsterdam, The Netherlands.ORCID 0000-0003-3584-8370

Funding

Dutch Cancer SocietyDutch Cancer Society and the Dutch Ministry of Health, Welfare and SportEuropean Union 101076170FAPESP 2017/2624-1FAPESP 2021/11220-8Oncode InstituteX-omics Initiative 184.034.019ZonMw 04510012110011
6 · The paper itself

Abstract

The nuclear receptor Nur77 plays a crucial, protective role in chronic inflammatory diseases and deficiency of Nur77 in macrophages results in excessive pro-inflammatory cytokine secretion. Previous research suggested that Nur77's regulatory function in inflammation is due to repression of the pro-inflammatory transcription factor NF-kB, but the underlying mechanism remains unclear. To address this, we applied a genome-wide, multi-omics approach in LPS-stimulated RAW264.7 macrophages with inducible Nur77 expression. Key findings were validated in wild-type and Nur77-deficient bone marrow-derived macrophages. We show that Nur77 suppresses the expression of inflammatory genes through a dual mechanism wherein Nur77 acts as a repressor of AP-1 targets at two levels: first, Nur77 occupies regulatory elements proximal to AP-1 target genes through AP-1 motifs and second, Nur77 regulates the expression of AP-1 family members themselves. These repressive activities of Nur77 result in diminished RNA Pol II on AP-1 genes and their targets. The first zinc finger of the Nur77 DNA-binding domain is required to reduce AP-1 activity. In summary, Nur77 represses macrophage inflammation through regulation of both immediate-early AP-1 expression, as well as inhibition of AP-1-driven gene programs.

Indexed as

Gene Expression RegulationInflammationMacrophagesNuclear Receptor Subfamily 4, Group A, Member 1Transcription Factor AP-1AnimalsLipopolysaccharidesMiceRAW 264.7 CellsRNA Polymerase IILipopolysaccharidesNr4a1 protein, mouseNuclear Receptor Subfamily 4, Group A, Member 1RNA Polymerase IITranscription Factor AP-1

Identifiers

PMID42605805
PMCPMC13478752

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.